These findings suggest that Ginsenoside Rg3 exerts a positive influence on the calcium cycling in cardiomyocytes of heart failure mice via SUMO1, which highlighted a potential therapeutic approach for heart failure through targeting SERCA2a SUMOylation [15]. The gene discussed is SUMO1; the disease is heart failure.